Reem Malki leads the quality functions at Alvotech, bringing almost 30 years of extensive experience as a dynamic and strategic quality leader to the company. She has a proven track record across a variety of product types including biosimilars, injectables, oral solids, medical devices and combination products. Prior to joining Alvotech she held various leadership roles at Mylan including Head of Global Quality Operations for both affiliates and third parties as well as OSD, API, injectables and biosimilars and VP of EMEA Quality Operations, among others.
Prior to Mylan, Reem held positions of increasing responsibility in quality control at Andrx Pharmaceuticals leading up to its acquisition by Watson, most recently as Director of Quality Control. She began her career in the pharmaceutical industry at Wyeth Ayerst Laboratories and Zymark Corporation.
Reem holds a Bachelor of Science in Chemistry from the University of Maine